Sanara MedTech (SMTI) Other Non-Current Liabilities (2010 - 2025)
Sanara MedTech's (SMTI) quarterly Other Non-Current Liabilities came in at $2.1 million in Q2 2025, down 20.46% YoY from $2.7 million in Q2 2024, and up 173.79% on a QoQ basis from $771001.0 in Q1 2025.
Sanara MedTech (SMTI) Other Non-Current Liabilities (2010 - 2025) Analysis & Trends
Sanara MedTech (SMTI) has 9 years of Other Non-Current Liabilities data on file, last reported at $2.1 million in Q2 2025.
- Quarterly Other Non-Current Liabilities fell 20.46% year-over-year to $2.1 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.1 million (down 20.46% YoY) and the FY2024 annual result came in at $748001.0, down 72.53% from the prior year.
- Other Non-Current Liabilities improved to $2.1 million in Q2 2025, from $771001.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $7.1 million in Q3 2022 to a low of $90293.0 in Q1 2021.
- A 5-year average of $3.0 million and a median of $2.7 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 7713.75% — and 2024, when it slumped 72.53%.
- Tracing SMTI's Other Non-Current Liabilities over 5 years: stood at $90293.0 in 2021, then surged by 6549.25% to $6.0 million in 2022, then plunged by 54.65% to $2.7 million in 2023, then tumbled by 72.53% to $748001.0 in 2024, then soared by 182.21% to $2.1 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $2.1 million (Q2 2025), $771001.0 (Q1 2025), and $748001.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 771,001.00 |
| Dec 31, 2024 | 748,001.00 |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.78 Mn |
| Dec 31, 2023 | 2.72 Mn |
| Sep 30, 2023 | 4.87 Mn |
| Jun 30, 2023 | 5.65 Mn |
| Mar 31, 2023 | 6.03 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 7.06 Mn |
| Jun 30, 2022 | 3.95 Mn |
| Sep 30, 2021 | 90,293.00 |
| Jun 30, 2021 | 90,293.00 |
| Mar 31, 2021 | 90,293.00 |
| Dec 31, 2020 | 90,293.00 |
| Sep 30, 2020 | 139,437.00 |
| Jun 30, 2020 | 77,092.00 |
| Mar 31, 2012 | 1,789.00 |